Epstein-Barr virus gene expression in nasopharyngeal carcinoma - PubMed (original) (raw)
Epstein-Barr virus gene expression in nasopharyngeal carcinoma
L S Young et al. J Gen Virol. 1988 May.
Abstract
Epstein-Barr virus (EBV), an agent with growth transforming potential for human B cells, is associated with certain B cell lymphomas in man and also with an epithelial tumour, undifferentiated nasopharyngeal carcinoma (NPC). Since B cell growth transformation is associated with the constitutive expression of a small number of EBV-coded latent proteins, the nuclear antigens EBNA 1, EBNA 2, EBNA 3 and EBNA-LP and the latent membrane protein (LMP), the present work sought to determine whether this same pattern of virus gene expression occurred in NPC. Tumour biopsies were taken from NPC patients from three areas of differing tumour incidence (Kenya, Algeria, Britain) and immediately snap-frozen, as were biopsies of non-EBV-related carcinomas for controls. Immunoblotting of PAGE-separated proteins with selected human sera identified 24 NPC biopsies clearly expressing EBNA 1. When the analysis was extended using selected human sera with antibodies against the other EBNAs, there was no detectable expression of EBNA 2, EBNA 3 or EBNA-LP in any of these 24 biopsies; their EBNA 2-negative status was confirmed using a monoclonal antibody (MAb) PE2 which was reactive in immunoblotting and in immunoprecipitation with EBNA 2A and EBNA 2B proteins. Similar experiments with two different LMP-specific MAbs, CS1 to 4 and S12, revealed heterogeneity between NPC biopsies; 9/24 biopsies were demonstrably LMP-positive, the degree of expression varying considerably between individual tumours in a manner which was not related to the level of EBNA 1 expression. None of the 24 NPC biopsies expressed detectable amounts of EBV lytic cycle antigens. A nude mouse-passaged NPC cell line, C15, likewise expressed EBNA 1 and LMP but none of the other EBV latent proteins nor lytic cycle antigens. This work identifies a novel type of EBV-cell interaction in NPC cells which is distinct from that seen in in vitro transformed B cell lines and from that seen to date in EBV-positive B cell lymphomas.
Similar articles
- The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
Ernberg I, Falk K, Minarovits J, Busson P, Tursz T, Masucci MG, Klein G. Ernberg I, et al. J Gen Virol. 1989 Nov;70 ( Pt 11):2989-3002. doi: 10.1099/0022-1317-70-11-2989. J Gen Virol. 1989. PMID: 2479717 - Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region.
Hu LF, Minarovits J, Cao SL, Contreras-Salazar B, Rymo L, Falk K, Klein G, Ernberg I. Hu LF, et al. J Virol. 1991 Mar;65(3):1558-67. doi: 10.1128/JVI.65.3.1558-1567.1991. J Virol. 1991. PMID: 1847471 Free PMC article. - Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.
Fåhraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P, et al. Fåhraeus R, et al. Int J Cancer. 1988 Sep 15;42(3):329-38. doi: 10.1002/ijc.2910420305. Int J Cancer. 1988. PMID: 2843473 - T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB, Murray RJ, Brooks J, Griffin H, Moss DJ, Masucci MG. Rickinson AB, et al. Cancer Surv. 1992;13:53-80. Cancer Surv. 1992. PMID: 1330300 Review. - Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
Kis LL, Takahara M, Nagy N, Klein G, Klein E. Kis LL, et al. Immunol Lett. 2006 Apr 15;104(1-2):83-8. doi: 10.1016/j.imlet.2005.11.003. Epub 2005 Dec 1. Immunol Lett. 2006. PMID: 16386314 Review.
Cited by
- Novel Therapies Boosting T Cell Immunity in Epstein Barr Virus-Associated Nasopharyngeal Carcinoma.
Renaud S, Lefebvre A, Mordon S, Moralès O, Delhem N. Renaud S, et al. Int J Mol Sci. 2020 Jun 16;21(12):4292. doi: 10.3390/ijms21124292. Int J Mol Sci. 2020. PMID: 32560253 Free PMC article. Review. - The expression and function of Epstein-Barr virus encoded latent genes.
Young LS, Dawson CW, Eliopoulos AG. Young LS, et al. Mol Pathol. 2000 Oct;53(5):238-47. doi: 10.1136/mp.53.5.238. Mol Pathol. 2000. PMID: 11091847 Free PMC article. Review. - Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.
Laux G, Dugrillon F, Eckert C, Adam B, Zimber-Strobl U, Bornkamm GW. Laux G, et al. J Virol. 1994 Nov;68(11):6947-58. doi: 10.1128/JVI.68.11.6947-6958.1994. J Virol. 1994. PMID: 7933076 Free PMC article. - Latent Epstein-Barr virus infection in cottontop tamarins. A possible model for Epstein-Barr virus infection in humans.
Niedobitek G, Agathanggelou A, Finerty S, Tierney R, Watkins P, Jones EL, Morgan A, Young LS, Rooney N. Niedobitek G, et al. Am J Pathol. 1994 Oct;145(4):969-78. Am J Pathol. 1994. PMID: 7943186 Free PMC article. - Alterations of the p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphomas.
Edwards RH, Raab-Traub N. Edwards RH, et al. J Virol. 1994 Mar;68(3):1309-15. doi: 10.1128/JVI.68.3.1309-1315.1994. J Virol. 1994. PMID: 8107196 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous